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ttp://dx.doi.org/10.1016/j.ajpath.2013.06.011Inﬂuenza A viruses from animal reservoirs have the capacity to adapt to humans and cause inﬂuenza
pandemics. The occurrence of an inﬂuenza pandemic requires efﬁcient virus transmission among
humans, which is associated with virus attachment to the upper respiratory tract. Pandemic severity
depends on virus ability to cause pneumonia, which is associated with virus attachment to the lower
respiratory tract. Recently, a novel avian-origin H7N9 inﬂuenza A virus with unknown pandemic
potential emerged in humans. We determined the pattern of attachment of two genetically engineered
viruses containing the hemagglutinin of either inﬂuenza virus A/Shanghai/1/13 or A/Anhui/1/13 to
formalin-ﬁxed human respiratory tract tissues using histochemical analysis. Our results show that the
emerging H7N9 virus attached moderately or abundantly to both upper and lower respiratory tract,
a pattern not seen before for avian inﬂuenza A viruses. With the caveat that virus attachment is only the
ﬁrst step in the virus replication cycle, these results suggest that the emerging H7N9 virus has the
potential both to transmit efﬁciently among humans and to cause severe pneumonia. (Am J Pathol
2013, 183: 1137e1143; http://dx.doi.org/10.1016/j.ajpath.2013.06.011)Supported by European Union FP7 ANTIGONE (contract number
278976), European Union FP7 FLUPIG (contract number 258084), NIAID-
NIH (contract HHSN266200700010C), NHMRC C.J. Martin post-doctoral
fellowship (1054081) (K.S.).
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B.V. and owns share certiﬁcates in ViroClinics Biosciences B.V. T.K. is
a part-time consultant for ViroClinics Biosciences B.V.Inﬂuenza A viruses from animal reservoirs have the capacity
to adapt to humans with the potential to cause human inﬂu-
enza pandemics. In the past 100 years, such inﬂuenza
pandemics have occurred four times (subtype H1N1 in 1918,
subtype H2N2 in 1957, subtype H3N2 in 1968, and subtype
H1N1 in 2009) causing estimated excess mortality ranging
from several hundred thousand to 50 million people.1
Recently, a novel avian-origin inﬂuenza A virus of the sub-
type H7N9 has emerged in humans.2 Little is known about this
virus including its potential to cause an inﬂuenza pandemic.
The properties and epidemiological circumstances of
a virus capable of causing an inﬂuenza pandemic include the
opportunity for a novel virus to cross the species barrier from
its non-human host species to humans, the ability of this virus
to productively infect humans, and the ability of this virus to
transmit efﬁciently among humans.3 The high mutation rate
of the inﬂuenza virus, coupled with the segmented nature of
its genome (which allows the generation of progeny viruses
that have gene segments from two or more parent viruses)stigative Pathology.
.provides the antigenic changes necessary to cause a
pandemic.4 The opportunity for such events to occur is
greatest in regions where high densities of people co-exist
with high densities of poultry, domestic pigs, and other
species that act as inﬂuenza virus reservoirs.5 The severity of
the subsequent pandemic depends largely on the ability of the
novel virus to cause pneumonia. This, in turn, is dependent
both on viral and host factors.6 Viral factors include speci-
ﬁcity of the hemagglutinin (HA) for receptors on host cells,
presence of a multibasic cleavage site in the HA, activity
level of the neuraminidase, transcription efﬁciency of the
polymerase complex proteins, and ability of non-structural
van Riel et alprotein 1 to antagonize the innate immune response. Host
factors are predominantly the existence of homosubtypic or
heterosubtypic immunity.
The ability of an inﬂuenza virus to attach to epithelial
cells at different levels of the human respiratory tractdits
pattern of virus attachmentdis associated with both trans-
missibility and virulence. The transmissibility of inﬂuenza
viruses correlates with the pattern of virus attachment to the
human upper respiratory tract (URT). Inﬂuenza viruses that
are transmitted efﬁciently among humans (such as human
seasonal inﬂuenza viruses) attach abundantly to human
URT, whereas inefﬁciently transmitted viruses [such as
highly pathogenic avian inﬂuenza (HPAI) H5N1 virus]
rarely attach to human URT.7e8 The difference in virulence
of human seasonal inﬂuenza viruses and HPAI H5N1 virus
correlates with the difference in the pattern of virus
attachment in bronchioles and alveoli: HPAI H5N1 virus
attaches more abundantly than human seasonal inﬂuenza
viruses to nonciliated cuboidal epithelial cells (Clara cells)
in the bronchioles and to type II pneumocytes and alveolar
macrophages in the alveoli.8e10
In March 2013, the ﬁrst human infections with a novel
avian-origin inﬂuenza A virus of the subtype H7N9 were
reported in three patients from eastern China. Based on
phylogenetic analysis, this novel avian inﬂuenza A H7N9
virus was identiﬁed as a reassortant virus with the HA most
closely related to an avian inﬂuenza A H7N3 isolate from
a duck, the neuraminidase most closely related to an avian
inﬂuenza A H7N9 isolate from an unspeciﬁed wild bird, and
the internal genes most closely related to an avian inﬂuenza
A H9N2 isolate from a brambling (Fringilla montifringilla;
a small passerine bird in the ﬁnch family). All three patients
developed severe pneumonia and acute respiratory distress
syndrome, ultimately resulting in death.2 As of May 30,
2013, novel H7N9 virus infection has been conﬁrmed in
China and in 132 patients in Taiwan, of whom 37 have died
[World Health Organization (WHO), http://www.who.int/
inﬂuenza/human_animal_interface/inﬂuenza_h7n9/08_Report
WebH7N9Number.pdf, last accessed July 22, 2013]. The
majority of patients with conﬁrmed H7N9 virus infection
had a history of exposure to live animals, with infected
poultry being the suspected source of H7N9 virus.11 Some
of the human isolates contained mutations in the polymerase
or HA genes associated with adaptation to the mammals. Of
speciﬁc interest is the Q226L amino acid substitution in HA,
which is known to be associated with a switch in the
receptor binding preference of HA from a2,3-linked sialic
acids to a2,6-linked sialic acids.12 In two family clusters,
there was a possible occurrence of limited human-to-human
transmission of H7N9 virus after close, prolonged, unpro-
tected contact.11 Unraveling the mechanism of attachment
of this novel virus may help to assess its potential trans-
missibility and virulence.
We therefore determined the pattern of attachment of
the emerging H7N9 viruses, with and without the Q226L
amino acid substitution, to human respiratory tract and1138compared it with that of human inﬂuenza viruses that
transmit efﬁciently among humans and have low intrinsic
virulence, and HPAI viruses that transmit inefﬁciently
among humans and have variable to high intrinsic virulence.
Materials and Methods
Ethics
Archival parafﬁn-embedded human tissues were obtained
from the Department of Pathology (Erasmus University
Medical Centre, Rotterdam, The Netherlands). Approval
from the Medical Research Ethics Committee was obtained
to use human archival respiratory tract tissues for virus
attachment studies (MEC-2011-129).
Viruses and Tissues
Reassortant viruses consisting of seven gene segments of
inﬂuenza virus A/PR/8/34 and theHA of either inﬂuenza virus
A/Shanghai/1/13 (H7 Shanghai) or A/Anhui/1/13 (H7 Anhui)
(emerging H7 virus group) were produced using reverse
genetics techniques as described previously.13e14 We used
synthetic open reading frame sequences based on sequences
deposited by the WHO Chinese National Inﬂuenza Center in
the Global Initiative on Sharing All Inﬂuenza Data (GISAID)
EpiFluDatabase. The original synthetic constructs were kindly
providedbyDr. RichardWebby. The sequence of theHAof the
recombinant viruses was conﬁrmed by real-time PCR and
sequencingusingprimers speciﬁc for the non-coding regionsof
HA. Contamination of the H7 virus stocks with other inﬂuenza
virus subtypes was excluded by a generic real-time RT-PCR
assay targeting HA of seasonal H1, and pandemic H1, H3, or
H5 (Table1).Toverify these results by an independentmethod,
HA of H7 Shanghai was ampliﬁed by PCR and subsequently
cloned into a commercial vector (TOPO TA cloning kit; Invi-
trogen, Carlsbad, CA). Of the 27 cloned fragments sequenced,
nomutations were observed at the receptor binding site, and no
H1, H3, or H5 HA was detected.
For comparison of pattern of attachment, a seasonal H3N2
virus (A/Netherlands/213/03) and pandemic H1N1 virus
(pH1N1; A/Netherlands/602/09) (human inﬂuenza virus
group) were included, as well as HPAI H5N1 virus (A/
Vietnam/1194/04) and HPAI H7N7 virus (A/Netherlands/
219/03) from human fatal cases (HPAI virus group). All
viruses were passaged in Madin-Darby canine kidney cells
and concentrated, inactivated, and ﬂuorescein isothiocyanate
(FITC)-labeled as described previously.9e10 Brieﬂy, viruses
were concentrated on a sucrose cushion and subsequently
pelleted and resuspended in a small volume of PBS.
Concentrated viruses were inactivated by dialysis against
0.1% formalin for 3 days. Inactivated viruses were labeled
with an equal volume of 0.1 mg/mL FITC (Sigma-Aldrich,
St. Louis, MO) in 0.5 mol/L bicarbonate buffer (pH 9.5).
The concentration of the different virus suspensions used
for virus histochemistry was standardized at 50 hemaggluti-
nation units/50 mL using hemagglutination assay.ajp.amjpathol.org - The American Journal of Pathology
Table 1 Oligonucleotide Primers and Probes Used for Real-Time RT-PCR Assay Targeting the HA Gene of Different Inﬂuenza A Viruses
Gene Sequence
H3 Forward 50-GGGAAAAGCTCAATAATGAGATCAG-30
H3 Reverse 50-TTGGGAATGCTTCCATTTGG-30
H3-1 Probe 50-TGCACCCATTGGCAAATGCAATTC-30
H3-2 Probe 50-TGCACCTATTGGCAAATGCAATTC-30
Seasonal H1-1 Forward 50-CCAAAGTATGTCAGGAGTGCAAAAT-30
Seasonal H1-2 Forward 50-CCAAAGTATGTCAGGAGTACAAAAT-30
Seasonal H1 Reverse 50-CCTTCAATGAAACCGGCAAT-30
Seasonal H1 Probe 50-TGGTTACAGGACTAAGGAACATCCCATCCA-30
Pandemic H1 Forward 50-GGAAAGAAATGCTGGATCTGGTA-30
Pandemic H1 Reverse 50-ATGGGAGGCTGGTGTTTATAGC-30
Pandemic H1 Probe 50-TGCAATACAACTTGTCAGACACCCAAGGG-30
H5 Forward 50-GGAACTTACCAAATACTGTCAATTTATTCA-30
H5 Reverse 50-CCATAAAGATAGACCAGCTACCATGA-30
H5 Probe 50-TTGCCAGTGCTAGGGAACTCGCCAC-30
H7N9 Binding to Human Respiratory TractIncluded human respiratory tract tissues consisted of the
nasal concha, trachea, bronchus, and lung tissues. The lung
tissues consisted of bronchi, bronchioles, and alveoli. All
tissues included were without histological lesions and were
from individuals without evidence of respiratory tract infec-
tion at the time of death. Given the scarcity of such tissues,
tissues from three individual donors were tested, except for
trachea, which was available from two donors. Age of the
donors (nZ 11, age of one donor unknown) ranged from 41
to 73 years, except for one donor who was 19 years of age.
Virus Histochemistry
The pattern of attachment of above-mentioned viruses was
determined in the same donor tissues. The pattern of attach-
ment of the viruses to human respiratory tract tissues was
determined by virus histochemistry as described pre-
viously.9e10Brieﬂy, formalin-ﬁxed, parafﬁn-embedded tissue
sections were deparafﬁnized in xylene and hydrated using
graded alcohols. FITC-labeled inﬂuenza viruses were incu-
bated overnight at a concentration of 50 hemagglutination
units/50 mL. For visualization by light microscopy, FITC was
detectedwith a peroxidase-labeled rabbiteanti-FITC (DAKO,
Glostrup, Denmark). The signal was ampliﬁed using a tyr-
amide ampliﬁcation system (Perkin-Elmer, Boston, MA).
Peroxidase was revealed with 3-amino-ethyl-carbozyle
(Sigma-Aldrich) resulting in a bright red precipitate. By light
microscopy, the percentage of cells to which inﬂuenza viruses
attached on the apical side was estimated and ranked on an
ordinal scale without knowledge of donor or virus identity:
rare (attachment to the apical side of<1% of epithelial cells),
occasional (< 10%), moderate (< 50%), and abundant (
50%). In addition, the main cell types to which inﬂuenza
viruses attached were determined based on morphological
characteristics and localization.
TRBC Hemagglutination Assay
Modiﬁed turkey red blood cells (TRBC) were prepared as
described previously15 but with slight modiﬁcations. Brieﬂy,The American Journal of Pathology - ajp.amjpathol.orgall a2,3-, a2,6-, a2,8-, and a2,9-linked sialic acids were
removed from the surface of TRBCs by incubating 62.5 mL
of 1% TRBCs in PBS with 50 mU Vibrio cholerae neur-
aminidase (VCNA; Roche, Almere, The Netherlands) in
8 mmol/L CaCl at 37C for 1 hour. Removal of sialic acids
was conﬁrmed by observation of complete loss of hemag-
glutination of the TRBCs by control inﬂuenza A viruses.
Subsequently, resialylation was performed using 0.25 mU
of a2,3-(N)-sialyltransferase (Cosmo Bio, Bio-Connect
B.V., Huissen, The Netherlands) or 12 mU of a2,6-(N)-
sialyltransferase (Cosmo Bio, Bio-Connect B.V.) and 1.5
mmol/L CMP-sialic acid (Sigma-Aldrich, Zwijndrecht, The
Netherlands) at 37C in 75 mL for 2 hours to produce a2,3-
TRBCs and a2,6-TRBCs, respectively. After washing, the
TRBCs were resuspended in PBS containing 1% bovine
serum albumin to a ﬁnal concentration of 0.5% TRBC.
Resialylation was conﬁrmed by hemagglutination of viruses
with known receptor speciﬁcity; recombinant viruses with
six gene segments of inﬂuenza virus A/PR/8/34 and HA and
neuraminidase of A/Vietnam/1194/04 H5N1 without the
basic cleavage site or with seven gene segments of inﬂuenza
virus A/PR/8/34 and theHA of A/Netherlands/213/03 H3N2.
Recombinant viruses with seven gene segments of inﬂuenza
virus A/PR/8/34 and the HA of A/Anhui/1/13 or of A/
Shanghai/1/13 were inactivated by treatment with b-propio-
lactone (Ferak Berlin, Berlin, Germany),16 and concentrated
through a 20% sucrose cushion. Next, the receptor speciﬁcity
was tested by performing a standard hemagglutination assay
with the modiﬁed TRBCs. In brief, serial two-fold dilutions
of virus in PBS were made in 50 mL volume; 50 mL of 0.5%
TRBCs were added, followed by incubation for 1 hour at 4C
before determining the hemagglutination titer.Results
The pattern of virus attachment to human respiratory tract
was similar within groups (human inﬂuenza viruses,
emerging H7 viruses, and HPAI viruses) with two excep-
tions. In the human inﬂuenza virus group, attachment to1139
Figure 1 Attachment of two reassortant viruses containing hemagglutinin of either inﬂuenza virus A/Shanghai/1/13 (H7 Shanghai) or A/Anhui/1/13
(H7 Anhui) to different parts of the upper and lower human respiratory tract. The attachment of a human seasonal inﬂuenza virus (H3N2) and a highly
pathogenic avian inﬂuenza virus (H5N1) is shown for comparison.
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Table 2 Attachment of Human Inﬂuenza Viruses, Emerging Avian Inﬂuenza H7 Viruses, and Highly Pathogenic Avian Inﬂuenza Viruses to
Different Parts of the Upper and Lower Human Respiratory Tract
Tissue n
Human inﬂuenza viruses Emerging avian inﬂuenza H7 viruses HPAI viruses
H3N2 pH1N1 H7 Shanghai H7 Anhui H7N7 H5N1
Score Cell type Score Cell type Score Cell type Score Cell type Score Cell type Score Cell type
Nasal concha 3 þþ Cil þ Cil þ Cil þþ Cil  ND  ND
Trachea 2 þþ* Cil þþ* Cil þ Cil þ Cil þ/ ND þ/ ND
Bronchus 3 þþ* Cil þþ* Cil þþ* Cil þþ* Cil þ/* ND þ/ ND
Bronchioles 3 þþ Cil þ Cil þþ Cil & Clara þþ Cil & Clara þ Clara þ Clara
Alveoli 3 þ Type I þ Type I þþy Type I & II þþy Type I & II þy Type II þy Type II
Scores are median scores from individual tissues. Attachment of inﬂuenza viruses was ranked on an ordinal scale as follows: , <1% cells positive; þ/,
<10% cells positive; þ, <50% cells positive; þþ, 50% cells positive
*Intracellular attachment to goblet cells.
yAdditional virus attachment to alveolar macrophages.
Cil, ciliated epithelial cells; Clara, Clara cells; ND, not determined; Type I, type I pneumocytes; Type II, type II pneumocytes.
Table 3 Receptor Speciﬁcity of the Emerging Avian Inﬂuenza H7
Viruses as Determined by a Modiﬁed Turkey Red Blood Cell (TRBC)
Hemagglutination Assay
Virus Subtype
Hemagglutination titer
(hemagglutination units/50 mL)
TRBC a2,3-TRBC a2,6-TRBC
A/Shanghai/1/13 H7N9 64 16 2
A/Anhui/1/13 H7N9 32 10 16
A/Netherlands/213/03 H3N2 32 0 32
A/Vietnam/1194/04 H5N1 32 32 0
Control viruses were A/Netherlands/213/03, with a known receptor
speciﬁcity for a2,6-linked sialic acids, and A/Vietnam/1194/04, with
a known receptor speciﬁcity for a2,3-linked sialic acids
H7N9 Binding to Human Respiratory Tractnasal respiratory epithelium and bronchiolar epithelium
was abundant for H3N2 and moderate for pH1N1. In the
emerging H7 group, attachment to nasal respiratory epithe-
lium was moderate for H7 Shanghai and abundant for H7
Anhui (Figure 1 and Table 2).
Human inﬂuenza viruses (H3N2 and pH1N1) attached
abundantly to the respiratory epithelium of nasal concha,
trachea, bronchus, and bronchioles with a preference for
ciliated cells over goblet cells. They attached moderately to
alveolar epithelium with a preference for type I pneumo-
cytes over type II pneumocytes.
Emerging H7 viruses (H7 Shanghai and H7 Anhui)
attached moderately to the respiratory epithelium of nasal
concha, trachea, and bronchus with a preference for ciliated
cells over goblet cells. They attached abundantly to both
ciliated and non-ciliated (Clara cells) cells of bronchioles and
to both type I pneumocytes and type II pneumocytes of
alveoli.
Highly pathogenic avian inﬂuenza viruses (H7N7 and
H5N1) attached rarely to respiratory epithelium of nasal
concha, trachea, and bronchus. They attached moderately to
epithelium of bronchioles (with a preference for Clara cells
over ciliated cells) and of alveoli (with a preference for type
II pneumocytes over type I pneumocytes).
Attachment to goblet cells was not seen in the nasal
concha for any viruses. Attachment to goblet cells was seen
in the trachea for human inﬂuenza viruses only, and in the
bronchus for all viruses except HPAI H5N1 virus. Attach-
ment to alveolar macrophages was seen for all viruses
except human inﬂuenza viruses.
The Q226L amino acid substitution in the HA has been
shown to change the receptor binding preference of the HA
protein from a2,3-linked sialic acids to a2,6-linked sialic
acids in other inﬂuenza viruses.17 To conﬁrm if Q226L
amino acid substitution could change the receptor binding in
HA of H7 Anhui,2 we tested its binding capacity to TRBCs
expressing either of these sialic acids. H7 Shanghai showed
predominant binding to a2,3-TRBCs with minimal binding
to a2,6-TRBCs (Table 3). In contrast, H7 Anhui showed
stronger binding to a2,6-TRBCs, although it retained someThe American Journal of Pathology - ajp.amjpathol.orgafﬁnity to a2,3-TRBCs. The receptor speciﬁcity of the
control viruses, A/Netherlands/213/03 and A/Vietnam/
1194/04, was as expected. A/Netherlands/213/03 bound
exclusively to a2,6-TRBC, whereas A/Vietnam/1194/04
bound exclusively to a2,3-TRBCs. These control viruses
also showed that modiﬁed TRBCs expressed amounts of
sialic acid that yielded equivalent hemagglutination titers to
the titers obtained with regular TRBCs.
Discussion
H7 Shanghai and H7 Anhui viruses show a pattern of
attachment not described before for any avian inﬂuenza
virus, namely abundant attachment to epithelial cells of both
upper and lower human respiratory tract. Like other avian
inﬂuenza viruses,7,9 H7 Shanghai and H7 Anhui viruses have
stronger attachment to lower parts of the human respiratory
tract than to upper parts. However, the pattern of attachment
of these emerging H7 viruses has three characteristics that are
different from other avian inﬂuenza viruses, such as HPAI
H5N1 and H7N7 viruses. First, the attachment to epithelial
cells in bronchioles and alveoli is more abundant. Second,
there is attachment to a broader range of cell types in bron-
chioles and alveoli. Third, the attachment to ciliated cells of
nasal concha, trachea, and bronchi is more abundant.1141
van Riel et alThe ﬁrst two characteristics (more abundant attachment
and broader range of cell types in bronchioles and alveoli) ﬁt
with increased virulence compared to that of human inﬂuenza
viruses. The attachment of HPAI H5N1 and H7N7 viruses to
epithelial cells in bronchioles and alveoli has been linked to
the development of viral pneumonia and acute respiratory
distress syndrome as primary disease from infection with
these viruses in humans.8e10 However, virus attachment to
target cells, although important, is not the only characteristic
for causing disease. Low pathogenic avian inﬂuenza H5 and
H6 viruses have the same pattern of attachment in the human
lower respiratory tract as H5N1 but are not known to cause
disease in humans.9 Other disease-causing characteristics
that are important include the ability to replicate in and be
released from host cells, to efﬁciently counteract the innate
immune response, and to induce pro-inﬂammatory cytokine
production by infected cells.18
The third characteristic (more abundant attachment to
respiratory epithelium of upper parts of respiratory tract)
suggests the potential for efﬁcient transmission among
humans.7 For H7 Anhui, a possible explanation for this
characteristic is the Q226L amino acid substitution in the
HA.2 As predicted from studies in other avian inﬂuenza
viruses,17 this amino acid substitution changed the receptor
binding preference of the HA protein from a2,3-linked sialic
acids to a2,6-linked sialic acids (Table 3). a2,6-linked sialic
acids aremore abundant on the human tracheal epitheliumand
might increase the ability of the virus to be transmitted by
air.19e20 However, this amino acid substitution was absent in
H7 Shanghai, which had the predicted speciﬁcity for a2,3-
linked sialic acids (Table 3). However, H7 Shanghai bound
just as well to human respiratory epithelium as H7 Anhui
except for moderate rather than abundant attachment to nasal
respiratory epithelium (Table 2). Therefore, there must be
other intrinsic factors in this virus that confer improved
attachment to ciliated epithelial cells in the upper parts of the
human respiratory tract. Other variables that inﬂuence the
binding speciﬁcity include glycosylation and sialylation close
to the receptor binding site21 forHAand the type of sialic acid,
alternative linkages,22 and sulfation and fucosylation of the
saccharide residues23 for the receptor.
Besides abundant attachment to respiratory epithelium of
upper respiratory tract, an inﬂuenza virus may require other
properties for efﬁcient airborne transmission. Although the
exact properties required for tranmission are not known, it
has been speculated that these include replication to high
titers in the URT and release and aerosolization of single
virus particles.24 The proteins forming the viral polymerase
complex are important for replication efﬁciency. Amino acid
substitutions in the polymerase proteins have been shown to
be the major determinants of host range and transmission,
and the amino acid substitution Glu627 to Lys627 in the
polymerase complex protein PB2 has been associated with
increased virus replication at the lower temperature of the
human URT than the core body temperature of birds.24e25
This amino acid substitution was also present in the HPAI1142H5N1 viruses that were transmitted by air among ferrets19 as
well as in the emerging H7N9 virus.12 For release and
aerosolization of single virus particles, neuraminidase, which
facilitates the release of newly formed virus particles budding
from the host cell membrane, needs to be in balance with the
HA. If not, the released particles may form virus aggregates,
as is seen in HPAI H5N1 virus.24 The fact that emerging
H7N9 virus can cause infection in individual cases, despite
its ability to attach abundantly to the human URT and possess
Glu627 to Lys627 substitution in PB2, suggests that it has not
acquired all of the necessary properties for efﬁcient trans-
mission among humans.
In conclusion, the pattern of attachment of H7 Shanghai
and H7 Anhui viruses have characteristics of both human and
avian inﬂuenza viruses, which have previously not been
observed in avian inﬂuenza viruses. These emerging H7
viruses have both moderate attachment to ciliated respiratory
epithelium of nasal cavity and tracheadwhich correlates
with efﬁcient transmission among humansdand abundant
attachment to both ciliated cells and Clara cells in bronchi-
oles and both type I pneumocytes and type II pneumocytes in
alveolidwhich ﬁts with high virulence in HPAI H5N1 and
H7N7 viruses. These results indicate, that based just on the
pattern of virus attachment, the H7N9 currently emerging in
China has the potential both to cause severe pulmonary
disease and to be efﬁciently transmitted among humans.
However, it needs to be recognized that attachment is only
the ﬁrst step in the replication cycle of inﬂuenza virus in its
host cell, and that other steps, as well as host response, need
to be taken into account to fully understand the potential of
these emerging H7 viruses to cause an inﬂuenza pandemic.Acknowledgments
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